Summary The effect of sodium butyrate on mouse and human melanoma cell lines was evaluated. Sodium butyrate (0.1-2mM) is shown to reduce the clonogenic potential of several melanoma cell lines. The antiproliferative effect of sodium butyrate is accompanied by a marked increase in the activity of the plasmamembrane bound enzyme y-glutamyl transpeptidase. Sodium butyrate treated cells acquire a well developed rough endoplasmic reticulum and accumulate fat droplets. The development of the endoplasmic reticulum is associated with a marked increase in the activity of the enzyme marker NADPH cytochrome c reductase. It is suggested that the phenotypic alterations induced by sodium butyrate may serve as markers for the action of this agent on melanoma cells and other tumours.
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Butyric acid, a natural four carbon fatty acid, is known as an inducer of differentiation in Friend erythroleukaemic cells (Leder & Leder, 1975; Reeves & Cserjesi, 1979) . In vivo application of sodium butyrate to a child with acute myelogenous leukaemia resulted in a partial remission (Novogrodsky et al., 1983) .
Butyric acid (or its sodium salt) also induce phenotypic alterations in a variety of solid tumour cell lines such as Hela cells (Fishman et al., 1974; Gosh & Cox, 1976) , neuroblastoma (Prasad, 1979; Rama & Prasad, 1984) , breast cancer cells (Abe & Kufe, 1984; Stevens et al., 1984, colorectal carcinoma (Dexter et al., 1981; Kim et al., 1980; Hertz & Halwer, 1982) and retinoblastoma (Kyritsis et al., 1984) . The anti-tumour effects of sodium butyrate that include growth inhibition and decrease in tumorigenicity (for review see Prasad, 1980; Wright, 1973; Leavitt et al., 1978; Reese et al., 1985; Nordenberg et al., 1986a, b) are accompanied by changes in enzyme activities (Simmons et al., 1975; Prasad, 1980; Dexter et al., 1981; Prager & Kanar, 1984) , receptor content (Fishman & Atikkan, 1979; Jahangeer et al., 1982) and histone structure (Sealy & Chulkley, 1978; Rubenstein et al., 1979) .
We have recently shown that sodium butyrate markedly inhibits B 16 mouse melanoma cell growth and alters the morphologic appearance of these cells. Growth inhibition was accompanied by a marked inhibition of tyrosinase activity (Nordenberg et al., 1986a) .
In the present study we further evaluate the effects of sodium butyrate on mouse melanoma cells and expand our studies to human malignant melanoma cells. Sodium butyrate is shown to inhibit clonogenicity of the different melanoma cells in soft agar. This anti-proliferative effect of sodium butyrate is associated with a marked increase in the activities of the plasma membrane bound enzyme y-glutamyl transpeptidase and NADPH cytochrome c reductase, a marker of the well developed endoplasmic reticulum.
These Hamburger and Salmon (1977) . Briefly, 5 x 103 single and viable cells in I ml RPMI medium containing 10% foetal calf serum and 0.3% agar were plated as a single layer in 30mm bacterial dishes (Sterilin). In one group of experiments the various concentrations of sodium butyrate were dispersed in the agar layer. In the second group of experiments cells were grown as a monolayer on tissue culture dishes, pretreated with sodium butyrate at various concentrations for 4 days, and then detached and plated in soft agar as above. Viability of the cells was assessed by the trypan blue exclusion test. Sodium butyrate was not included in the soft agar. The plates were incubated at 37°C in (5% C02, 95% air) humidified atmosphere and the colonies were scored after 14 days.
Extraction and determination of enzyme activities About 106 cells were incubated in 10 ml culture medium in the presence and absence of sodium butyrate for 3-4 days. For extraction of y-glutamyl transpeptidase, plates were briefly washed with cold PBS. Cells from 1-2 plates (3-S x 106 cells) were scraped with a rubber policemen and dispersed in 0.5ml TRIS-HC1 buffer (O.IM, pH=8), containing 0.15 M NaCl. y-Glutamyl transpeptidase was determined with L-y-glutamyl p-nitro anilide as previously described (Novogrodsky et al., 1976; Tate & Meister, 1974) . Enzyme activity was expressed as ,u mol product (p-nitro anilide) formed h -1 mg-1 DNA. DNA was measured in cell lysates by the method of Burton (1956) . Lysates were prepared by repeated freezing and thawing of the cell suspensions.
For determination of NADPH cytochrome c reductase -3 x 106 cells were washed with cold PBS, scraped with a rubber policeman and placed in glass tubes. Extracts were prepared by repeated (3 times) freezing and thawing of 1.5 x 106 cells in 0.1 ml TRIS-HCl buffer (pH 7.4, 0.1 M) containing MgCl (1 mM) and CaCl2 (1 mM). Enzyme activity was determined spectrophotometrically at 30°C as described by Phillips and Langdon (1962) using 2,6 dichlorophenolindophenol as electron acceptor. Enzyme activity was expressed as n mol acceptor reduced min-mg-DNA.
Transmission electron microscopy Cells were washed with cold phosphate buffered saline, scraped with a rubber policeman and fixed in 2% glutaraldehyde. The cells were stained with uranyl acetate, postfixed in osmium tetroxide, dehydrated in graded alcohol solutions and embbed in Epon (812). Thin sections were cut with a LKB ultratome III and examined with a Jeol lOOctransmission electron microscope (Glauert, 1973) .
Lipid staining Cell culture dishes were washed with PBS, fixed overnight with formol-calcium and stained by the Oil Red 0 method (Pearse, 1968) . The stained cell cultures were covered with cover slips using the glycerine jelly mount.
Results
The effect of sodium butyrate on the cloning efficiency in soft agar of mouse and human melanoma cell lines is depicted in Figure 1 . The results indicate that sodium butyrate at 1 mM completely inhibits the ability of the three types of melanoma cells to form colonies in soft agar. Concentrations of 0.1-0.5 mm have a marked inhibitory effect on clonogenicity in soft agar. It should be noted that sodium butyrate at these concentrations does not affect cell viability. Pre-treatment of the human melanoma cells with sodium butyrate prior to culturing them in the soft agar reduces the capacity of the cells to form colonies (Table I ). These data suggest that sodium butyrate reduces the malignant potential of the cells. The present data are in accordance with our previous finding that pre-treatment of B16 FlO mouse melanoma cells with sodium butyrate prior to their inoculation in syngeneic C57/Bl mice resulted in a delay of tumour appearance (Nordenberg et al., 1986a) .
The anti-proliferative effect of sodium butyrate is accompanied by phenotypic alterations that include morphological and biochemical changes. We measured the activity of the plasma membrane bound enzyme y-glutamyl transpeptidase in the three melanoma cell lines. The level of this enzyme, that has been implicated to participate in amino acid transport, varies in the three cell lines. Sodium butyrate treatment, however, markedly enhances the activity of this enzyme in all three cell lines (Figure 2 -no direct effect on this enzyme and at least 24 h were 6/84 required for induction of this enzyme. Twenty-four hour 1.5 ** treatment with sodium butyrate resulted in a two fold increase in the activity of y-glutamyl transpeptidase in B16 I: F0 melanoma cells. Three days of treatment resulted in a E four fold increase in the activity of this enzyme (Figure 2) . We have recently shown that sodium butyrate also enhances Z the activity of another membrane bound enzyme, alkaline phosphatase in 6/84 human melanoma cells (Nordenberg et cm al., 1985; 1986b) . E Transmission electron-microscopy of sodium butyratetreated B16 FIO melanoma cells revealed a marked 1.0 B 16F-1O development of the endoplasmic reticulum (Figure 3) . The results depicted in Figure 4 shows that NADPH cytochrome°* 0. c reductase, a marker enzyme of the endoplasmic reticulum is markedly enhanced in the sodium butyrate-treated cells.
SKMEL-28 Figure 3 and 5 show that sodium butyrate-treated mouse This enzyme is a key enzyme for adipose differentiation (Wawra, 1986) . (Fiala et at., 1972; Novogrodsky et at., 1976; Mohandas et at., 1984; Chen & ' d p,,.~~~~Haskill, 1984; Chiba & Jimbow, 1986) . In melanoma this enzyme has been suggested to convert glutathione-dopa to 5-s-cysteinyldopa Mojamdar et at., 1982). We have recently found increased activity of y-glutamyl transpeptidase iñ~*~l eukaemic cells treated with sodium butyrate in vitro and in vivo. The elevated enzyme activity was in correlation with ""~'"~e levated differentiation markers of leukaemic cells (Rephaeli et al., 1986) . Interestingly, sodium butyrate markedly enhances the activity of another membrane bound enzyme, .
alkaline phosphatase in human 6/84 cells (Nordenberg et al., 1985 (Nordenberg et al., , 1986b . Wennersten Jimbow & Vesugi, 1982 . NADPH cytochrome c reductase was recently found to be increased in B16 melanoma cells following treatment with LiCI (Nordenberg et al., 1987) and derivatives of dimethylthiourea (unpublished data). These agents also inhibit melanoma cell growth and induce several differentiated features in these cells. It should be noted that sodium butyrate also induced a marked increase in rough endoplasmic reticulum in lymphoblastoid cells (Asai et al., 1984) . The present findings suggest that sodium butyrate acts as a biological modifier with potential anti-tumour properties on melanoma cells. It induces selective phenotypic alterations rather than a coordinated pattern of differentiation. It is unclear whether the enhancement of y-glutamyl transpeptidase, or the accumulation of lipid droplets, reflect differentiated features. The development of the endoplasmic reticulum and enhancement of NADPH cytochrome c reductase activity might represent differentiated characteristics, since normal melanocyte maturation is associated with the development of endoplasmic reticulum.
It has been suggested that biologically modified cancer cells might be more sensitive towards other therapeutic modalities (Rama & Prasad, 1984; Leith et al., 1982; Kyritsis et al., 1984) . Recently it has been reported that butyrate enhances the synthesis of interphotoreceptor retinoid binding protein in Y-79 human retinoblastoma cells (Kyritsis et al., 1985) . Combined treatment of these cells with sodium butyrate resulted in synergistic anti-proliferative effects (Kyritsis et al., 1984 
